Chemed Corporation
Chemed Corporation Q1 FY2026 earnings call
April 24, 2026 · fiscal period ended 2026-03
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-04-24
Management highlights
VITAS performance exceeded expectations with 2.2% days of care increase and Medicare reimbursement rate increase. Roto-Rooter saw core residential service revenue increase, added 18 new commercial business managers. VITAS added over $32.5 million to cap cushion in Florida combined program. Roto-Rooter acquired franchises in SF and Fort Worth, expected to add $5 - $5.5 billion revenue in 2026.
Segment performance
VITAS: Net revenue was $420 million in Q1 2026, up 3.1% y-o-y. Revenue increase due to 2.2% days of care increase and ~2.6% Medicare reimbursement rate increase. Average revenue per day was $210.62. Adjusted EBITDA excluding Medicare cap was $70.8 million, up 0.6% y-o-y, margin 16.8%. Roto-Rooter: Branch commercial revenue $56.5 million, down 1.9% y-o-y. Residential revenue $166.3 million, down 1.5% y-o-y. Adjusted EBITDA $53.5 million, down 9.6% y-o-y, margin 22.5%, down 218 basis points.
Guidance
Full year ADC growth for 2026 updated to 4.5% - 5.5% from 3.5% - 4%. Anticipated revenue growth excluding Medicare cap revised to 6.5% - 7.5% from 5.5% - 6.5%. EBITDA margin excluding Medicare cap 18% - 18.5%. Roto-Rooter revenue growth unchanged at 3 - 3.5%, adjusted EBITDA margin 21.5% - 22.5%.
Risks
Roto-Rooter affected by weather events, Google algorithm changes, independent contractor performance, water restoration price per job issues.
Q&A highlights
Q: On VITA margins and headcount, A: Averaged ~100 FTEs below budget, intend to add 60 FTEs per month.
Q: On Roto-Rooter marketing costs, A: Spent $3 million more in Q1, expect marketing costs to continue.
Q: On Florida cushion and rate update, A: Rate increase in Florida might be slightly lower than national average, still crunching numbers.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | $5.65 | $5.30 | +6.6% | — |
| Revenue | $657.5M | $649.8M | +1.2% | — |
Transcript
April 24, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.